Default object view. Click to create a custom template, Node ID: 136524, Object ID: 80459

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomis...

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial

No relation

Yes

No relation

No

09/03/2016 3:36 pm

No